Sabby Management, LLC Biora Therapeutics, Inc. Transaction History

Sabby Management, LLC

$130,000
Q3 2024

Shares

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 14, 2023	SELL	$0.13 - $12.03 $24,524 - $2.27 Million	-188,648 Reduced 65.58%	98,993 $12,000
Q3 2022 Nov 14, 2022	SELL	$0.53 - $13.3 $66,600 - $1.67 Million	-125,662 Reduced 30.4%	287,641 $139,000
Q2 2022 Aug 15, 2022	SELL	$0.56 - $1.22 $48,190 - $104,985	-86,054 Reduced 17.23%	413,303 $289,000
Q1 2022 May 16, 2022	SELL	$1.11 - $2.25 $648,671 - $1.31 Million	-584,389 Reduced 53.92%	499,357 $579,000
Q4 2021 Feb 14, 2022	BUY	$1.35 - $4.89 $1.46 Million - $5.3 Million	1,083,746 New	1,083,746 $2.27 Million

Others Institutions Holding BIOR

# of Institutions

2

Shares Held

890

Call Options Held

0

Put Options Held

0

About BIORA THERAPEUTICS, INC.

Ticker BIOR
Exchange NASDAQ
Shares Outstandng 186,623,605
Market Cap $299M
Description
Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and systemic therapeutics program uses an ing...

More about BIOR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sabby Management, LLC with notifications on news.